These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The evaluation of heparin in control of metastasis of Nb rat androgen-insensitive prostate carcinoma.
    Author: Drago JR, Weed P, Fralisch A.
    Journal: Anticancer Res; 1984; 4(3):171-2. PubMed ID: 6540544.
    Abstract:
    The Nb rat prostatic adenocarcinoma model has served as an animal model for testing various chemotherapeutic agents. This model has two tumor types: androgen-sensitive and androgen-insensitive. Herein, the androgen-insensitive tumor A.I.-II was evaluated in 52 animals, with heparin, heparan, 5-Fu, and cis-platinum for their effects on incidence of metastatic disease. Multiple experiments were previously carried out utilizing this tumor, which consistently has had an incidence of metastatic disease in 40-50% of the animals so implanted. Heparin at both doses and heparan significantly reduced metastasis in this study; however, they were not significant in reducing final tumor volumes as compared to the controls. 5-Fluorouracil at the dose evaluated neither significantly altered tumor volume nor altered metastatic disease. On the other hand, cis-platinum was significantly effective in lowering both metastatic disease and tumor volume (p less than 0.05).
    [Abstract] [Full Text] [Related] [New Search]